InfoChem builds on retrosynthestic analysis system by Optibrium

Published: 19-Mar-2019

Collaboration enables drug discovery researchers to generate alternative synthesis pathways for target molecules

Optibrium has announced a collaboration with InfoChem surrounding the software package StarDrop that designs, optimises and analyses small molecules. Optibrium is a UK company that developed the software, and Infochem is the German cheminformatics company contributing to improving it.

The collaboration provides StarDrop users with easy access to ICSYNTH light, an entry-level version of InfoChem’s computer-aided synthesis design (CASD) software to generate synthesis pathways for a target molecule. By stimulating new and unbiased ideas, researchers can explore alternative or novel synthetic routes with the potential to save time and reduce costs.

StarDrop connects with a wide variety of internal and external informatics systems, providing users with full support for compound design and optimisation through a single interface.

ICSYNTH light uses a transform-based approach to generate synthesis pathways for target molecules, even if these are novel and/or unpublished. The cheminformatics algorithm suggests precursors using chemical rules automatically generated from reaction databases, with machine learning approaches.

The results can then be explored as a synthetic tree with each step supported by literature citations describing a similar precedented transformation.

StarDrop can access ICSYNTH light to evaluate possible synthetic pathways for new molecules designed in StarDrop’s interactive designer or Nova module. This provides a tool for chemists to easily understand the synthetic tractability of proposed new molecules.

Commenting on the collaboration, Dr Matthew Segall, Optibrium’s CEO, said: “This partnership with InfoChem continues our collaborative approach to working with leading providers of technology and services for drug discovery and other chemistry fields.”

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
  2. You need to be a subscriber to read this article.
    Click here to find out more.

You may also like